It is reported that ablation of a p53-dependent senescence program in HSCs increases liver fibrosis and cirrhosis, and enhances the progression to hepatocellular carcinoma (Lujambio et al., 2013). The gene discussed is TP53; the disease is Hepatic fibrosis.